We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
Cap. Flow
+$2.14B
Cap. Flow %
9.89%
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34M
2
XOM icon
ExxonMobil
XOM
+$33.1M
3
JNJ icon
Johnson & Johnson
JNJ
+$32.7M
4
MMM icon
3M
MMM
+$32.4M
5
MCD icon
McDonald's
MCD
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Financials 12.4%
3 Industrials 11.69%
4 Healthcare 11.57%
5 Consumer Staples 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXNX
1426
DELISTED
Axonics, Inc. Common Stock
AXNX
$262K ﹤0.01%
+9,459
New +$226K
PDCE
1427
DELISTED
PDC Energy, Inc.
PDCE
$262K ﹤0.01%
10,015
+1,357
+16% +$32.6K
CDE icon
1428
Coeur Mining
CDE
$15.6B
$261K ﹤0.01%
32,297
+7,230
+29% +$44.6K
EGBN icon
1429
Eagle Bancorp
EGBN
$867M
$261K ﹤0.01%
5,361
+651
+14% +$29.5K
PSMT icon
1430
Pricesmart
PSMT
$5.75B
$260K ﹤0.01%
3,660
+537
+17% +$38.6K
R icon
1431
Ryder
R
$10.3B
$260K ﹤0.01%
4,791
+513
+12% +$26.7K
AMBA icon
1432
Ambarella
AMBA
$2.99B
$259K ﹤0.01%
4,282
+684
+19% +$37.9K
AN icon
1433
AutoNation
AN
$6.97B
$259K ﹤0.01%
5,316
+569
+12% +$28.8K
BMCH
1434
DELISTED
BMC Stock Holdings, Inc
BMCH
$259K ﹤0.01%
+9,031
New +$254K
RVNC
1435
DELISTED
Revance Therapeutics, Inc.
RVNC
$258K ﹤0.01%
15,873
-1,081
-6% -$16.8K
ALRM icon
1436
Alarm.com
ALRM
$2.56B
$257K ﹤0.01%
5,983
+877
+17% +$39.5K
ATKR icon
1437
Atkore
ATKR
$2.59B
$257K ﹤0.01%
+6,345
New +$235K
RDFN
1438
DELISTED
Redfin
RDFN
$257K ﹤0.01%
12,136
+2,077
+21% +$39.8K
COLM icon
1439
Columbia Sportswear
COLM
$3.19B
$255K ﹤0.01%
+2,541
New +$241K
MD icon
1440
Pediatrix Medical
MD
$2.16B
$255K ﹤0.01%
+9,193
New +$231K
MWA icon
1441
Mueller Water Products
MWA
$3.92B
$255K ﹤0.01%
21,282
+3,399
+19% +$38.8K
ANIP icon
1442
ANI Pharmaceuticals
ANIP
$1.77B
$253K ﹤0.01%
4,106
-442
-10% -$29.3K
GEF icon
1443
Greif
GEF
$4.47B
$253K ﹤0.01%
+5,732
New +$237K
PODD icon
1444
Insulet
PODD
$11.3B
$253K ﹤0.01%
1,478
+60
+4% +$10K
SBCF icon
1445
Seacoast Banking Corp of Florida
SBCF
$3.26B
$253K ﹤0.01%
+8,260
New +$235K
IBP icon
1446
Installed Building Products
IBP
$6.13B
$252K ﹤0.01%
+3,658
New +$247K
LADR
1447
Ladder Capital
LADR
$1.25B
$252K ﹤0.01%
13,960
+2,230
+19% +$38.5K
BEAT
1448
DELISTED
BioTelemetry, Inc.
BEAT
$252K ﹤0.01%
+5,433
New +$235K
KEM
1449
DELISTED
KEMET Corporation
KEM
$252K ﹤0.01%
+9,314
New +$226K
OPLN
1450
Openlane
OPLN
$4.17B
$251K ﹤0.01%
11,515
+880
+8% +$20.1K

Similar funds

ProShare Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.

  • ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
  • ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
  • ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
  • ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
  • ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
  • ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
  • ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.